Modern Care Journal

Published by: Kowsar

Zolpidem Induces Depersonalization and Derealization Symptoms: A Case Report

Mohammad Reza Abedini 1 and Aliakbar Esmaeili 2 , *
Authors Information
1 Cellular and Molecular Research Center, Associate Professor of Pharmacology, Birjand University of Medical Sciences, Birjand, Iran
2 Assistant Professor of Psychiatry, Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran
Article information
  • Modern Care Journal: April 2017, 14 (2); e11424
  • Published Online: January 31, 2017
  • Article Type: Case Report
  • Received: November 7, 2016
  • Revised: November 30, 2016
  • Accepted: December 28, 2016
  • DOI: 10.5812/modernc.11424

To Cite: Abedini M R, Esmaeili A. Zolpidem Induces Depersonalization and Derealization Symptoms: A Case Report, Mod Care J. 2017 ; 14(2):e11424. doi: 10.5812/modernc.11424.

Abstract
Copyright © 2017, Modern Care Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
References
  • 1. Mortaz Hejri S, Faizi M, Babaeian M. Zolpidem induced suicide attempt, a case report. DARU J Pharm Sci. 2013;21(77). doi: 10.1186/2008-2231-21-77.
  • 2. Janjic V, Radmanovic B, Dejanovic SD, Ravanic D, Borovcanin M. P.8.b.006 Side effects of zolpidem and temazepam in treating primary insomnia. Eur Neuropsychopharmacol. 2014;24:737-8. doi: 10.1016/s0924-977x(14)71188-5.
  • 3. Aronson JK. Meylers side effects of drugs, (sixteenth edition). Sixteenth ed. Oxford: Elsevier; 2016. p. 588-95.
  • 4. Sadock BJ, Sadock VA, Ruiz P. Kaplan and sadock s synopsis of psychiatry bhavioral science,clinical psychiatry. Philadelphia: Wolters kluwer; 2015.
  • 5. Fagioli F, Dell'Erba A, Migliorini V, Stanghellini G. Depersonalization: physiological or pathological in adolescents?. Compr Psychiatry. 2015;59:68-72. doi: 10.1016/j.comppsych.2015.02.011. [PubMed: 25748214].
  • 6. Kolev OI, Georgieva-Zhostova SO, Berthoz A. Anxiety changes depersonalization and derealization symptoms in vestibular patients. Behav Neurol. 2014;2014:847054. doi: 10.1155/2014/847054. [PubMed: 24803735].
  • 7. Hollander E, Hwang MY, Mullen LS, DeCaria C, Stein DJ, Cohen L. Clinical and research issues in depersonalization syndrome. Psychosomatics. 1993;34(2):193-4. doi: 10.1016/S0033-3182(93)71919-2. [PubMed: 8456168].
  • 8. Arlington V. Diagnostic and statistical manual of mental disorders. 5 ed. Missouri, United States: American Psychiatric Publishing; 2014. American psychiatric association.
  • 9. Hoyer J, Braeuer D, Crawcour S, Klumbies E, Kirschbaum C. Depersonalization/derealization during acute social stress in social phobia. J Anxiety Disord. 2013;27(2):178-87. doi: 10.1016/j.janxdis.2013.01.002. [PubMed: 23434546].
  • 10. Lambert MV, Senior C, Fewtrell WD, Phillips ML, David AS. Primary and secondary depersonalisation disorder: a psychometric study. J Affect Disord. 2001;63(1-3):249-56. [PubMed: 11246104].
  • 11. Dietl T, Bien C, Urbach H, Elger C, Kurthen M. Episodic depersonalization in focal epilepsy. Epilepsy Behav. 2005;7(2):311-5. doi: 10.1016/j.yebeh.2005.05.023. [PubMed: 16046278].
  • 12. Hunter EC, Baker D, Phillips ML, Sierra M, David AS. Cognitive-behaviour therapy for depersonalisation disorder: an open study. Behav Res Ther. 2005;43(9):1121-30. doi: 10.1016/j.brat.2004.08.003. [PubMed: 16005701].
  • 13. Hunter EC, Phillips ML, Chalder T, Sierra M, David AS. Depersonalisation disorder: a cognitive-behavioural conceptualisation. Behav Res Ther. 2003;41(12):1451-67. [PubMed: 14583413].
  • 14. Jay EL, Sierra M, Van den Eynde F, Rothwell JC, David AS. Testing a neurobiological model of depersonalization disorder using repetitive transcranial magnetic stimulation. Brain Stimul. 2014;7(2):252-9. doi: 10.1016/j.brs.2013.12.002. [PubMed: 24439959].
  • 15. Steinberg M. Encyclopedia of stress, (second edition). Second ed. In: Fink G, editor. New York: Academic Press; 2007. Depersonalization, systematic assessment; p. 736-40. doi: 10.1016/b978-012373947-6.00116-1.
  • 16. Tsai JH, Yang P, Chen CC, Chung W, Tang TC, Wang SY, et al. Zolpidem induced amnesia and somnambulism: rare occurrences?. Eur Neuropsychopharmacol. 2009;19(1):74-6. doi: 10.1016/j.euroneuro.2008.08.007. [PubMed: 18819779].
  • 17. Yang W, Dollear M, Muthukrishnan SR. One rare side effect of zolpidem--sleepwalking: a case report. Arch Phys Med Rehabil. 2005;86(6):1265-6. doi: 10.1016/j.apmr.2004.11.022. [PubMed: 15954071].
  • 18. Yun CH, Ji KH. Zolpidem-induced sleep-related eating disorder. J Neurol Sci. 2010;288(1-2):200-1. doi: 10.1016/j.jns.2009.09.026. [PubMed: 19822330].
  • 19. Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH. Association Between Zolpidem and Suicide: A Nationwide Population-Based Case-Control Study. Mayo Clin Proc. 2016;91(3):308-15. doi: 10.1016/j.mayocp.2015.10.022. [PubMed: 26776243].
  • 20. Sierra M, David AS. Depersonalization: a selective impairment of self-awareness. Conscious Cogn. 2011;20(1):99-108. doi: 10.1016/j.concog.2010.10.018. [PubMed: 21087873].
  • 21. Phillips ML, Medford N, Senior C, Bullmore ET, Suckling J, Brammer MJ, et al. Depersonalization disorder: thinking without feeling. Psychiatry Res. 2001;108(3):145-60. [PubMed: 11756013].
  • 22. Mula M, Pini S, Cassano GB. The neurobiology and clinical significance of depersonalization in mood and anxiety disorders: a critical reappraisal. J Affect Disord. 2007;99(1-3):91-9. doi: 10.1016/j.jad.2006.08.025. [PubMed: 16997382].
  • 23. Mula M, Pini S, Preve M, Masini M, Giovannini I, Cassano GB. Clinical correlates of depersonalization symptoms in patients with bipolar disorder. J Affect Disord. 2009;115(1-2):252-6. doi: 10.1016/j.jad.2008.08.001. [PubMed: 18786726].
  • 24. Pikwer A. Depersonalization disorder may be related to glutamate receptor activation imbalance. Med Hypotheses. 2011;77(4):593-4. doi: 10.1016/j.mehy.2011.06.041. [PubMed: 21742442].
  • 25. Preve M, Mula M, Cassano GB, Pini S. Venlafaxine in somatopsychic and autopsychic depersonalization. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(8):1808-9. doi: 10.1016/j.pnpbp.2011.06.011. [PubMed: 21740948].
  • 26. Raimo EB, Roemer RA, Moster M, Shan Y. Alcohol induced depersonalization. Biol Psychiatry. 1999;45(11):1523-6. doi: 10.1016/s0006-3223(98)00257-1.
  • 27. Simeon D, Hollander E, Stein DJ, DeCaria C, Cohen LJ, Saoud JB, et al. Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine. Psychiatry Res. 1995;58(2):161-4. [PubMed: 8570768].
  • 28. Stein MB, Uhde TW. Depersonalization disorder, effects of caffeine and response to pharmacotherapy. Biol Psychiatry. 1989;26(3):315-20. doi: 10.1016/0006-3223(89)90044-9.
  • 29. Black DW, Wojcieszek J. Depersonalization syndrome induced by fluoxetine. Psychosomatics. 1991;32(4):468-9. doi: 10.1016/S0033-3182(91)72058-6. [PubMed: 1961868].
  • 30. Hollander E, Cohen L, DeCaria C, Stein DJ, Trungold-Apter S, Islam M. Fluoxetine and depersonalization syndrome. Psychosomatics. 1992;33(3):361-2. doi: 10.1016/S0033-3182(92)71984-7. [PubMed: 1410214].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments